Walter E. DeWolf - Concepedia

Author

Walter E. DeWolf

Also Known As

W E DeWolf, W deWolf, W. DeWolf, W. E. JUN. DEWOLF, W.E. DeWolf, Walter DeWolf, Walter Dewolf, Walter E DeWolf, Walter E. DeWOLF, Walter E. DeWolf

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Array BioPharma (United States)New Frontier GlaxoSmithKline (United States)Amgen (United States)Temple University

About

Walter E. DeWolf is an author at Array BioPharma (United States) specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	26	1.5K
2	Biochemistry	19	25	1.2K
3	Natural Sciences	16	19	949
4	Engineering	3	3	118
5	Health Sciences	1	1	19

Walter E. DeWolf

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion–Positive Solid Tumors Alexander Drilon, Ramamoorthy Nagasubramanian, James F. Blake, Cancer Discovery	2017	419
Potent and Selective Nonpeptide Inhibitors of Caspases 3 and 7 Inhibit Apoptosis and Maintain Cell Functionality Dennis Lee, Scott A. Long, Jerry L. Adams, Journal of Biological Chemistry	2000	232
Potent and Selective Nonpeptide Inhibitors of Caspases 3 and 7 Dennis Lee, Scott A. Long, Jeffrey H. Murray, Journal of Medicinal Chemistry Chemoprevention StrategyApoptosisImmunologyCell DeathPharmacotherapy	2001	164
Discovery of a Novel and Potent Class of FabI-Directed Antibacterial Agents David Payne, William H. Miller, Valerie Berry, Antimicrobial Agents and Chemotherapy	2002	163
Indole Naphthyridinones as Inhibitors of Bacterial Enoyl-ACP Reductases FabI and FabK Mark A. Seefeld, William H. Miller, Kenneth A. Newlander, Journal of Medicinal Chemistry Bioorganic ChemistryChemical BiologyPharmaceutical ChemistryDrug ResistanceMedicinal Chemistry	2003	161
1,4-Cyclohexanecarboxylates: Potent and Selective Inhibitors of Phosophodiesterase 4 for the Treatment of Asthma Siegfried B. Christensen, Aimee M. Guider, Cornelia J. Forster, Journal of Medicinal Chemistry	1998	150
1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI) Dirk A. Heerding, George Chan, Walter E. DeWolf, Bioorganic & Medicinal Chemistry Letters Inhibitory ActivityMedicinal ChemistryAntimicrobial Drug DiscoveryBiochemistryMedicine	2001	124
Discovery of Aminopyridine-Based Inhibitors of Bacterial Enoyl-ACP Reductase (FabI) William H. Miller, Mark A. Seefeld, Kenneth A. Newlander, Journal of Medicinal Chemistry Medicinal ChemistryPharmaceutical ChemistryBioorganic ChemistryAntibioticsBiochemistry	2002	109
Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK) Hédia Marrakchi, Walter E. DeWolf, Chad Quinn, Biochemical Journal Acyl-carrier ProteinCellular EnzymologyBiochemistryPneumoniae BelongsNadh-dependent Reductase	2003	109
TL1, a Novel Tumor Necrosis Factor-like Cytokine, Induces Apoptosis in Endothelial Cells Tianli Yue, Jian Ni, Anne M. Romanic, Journal of Biological Chemistry	1999	103

Page 1